STOCK TITAN

Freshpet (FRPT) CEO trades 84K options and 44K shares in plan

(Neutral)
(Neutral)
Form Type
4

Rhea-AI Filing Summary

Freshpet, Inc. (FRPT) reported insider transactions by CEO and director William B. Cyr involving option exercises and share sales. On August 17, 2026, he exercised options covering 84,000 shares of common stock at an exercise price of $10.23 per share, including direct and indirect holdings through his spouse and related trusts. The same day, entities associated with him sold a total of 44,067 common shares, including 41,022 shares at $72.86 and additional indirect sales at $72.41 per share, under a Rule 10b5-1 trading plan adopted on November 5, 2025. Following the option exercises, he and related entities continued to hold substantial option positions, including 243,548 options directly and additional indirect options in family-related trusts, all originally granted under Freshpet’s 2014 Omnibus Incentive Plan and fully vested as of December 31, 2020.

Positive

  • None.

Negative

  • None.
Insider Cyr William B.
Role Chief Executive Officer
Sold 44,067 shs ($3.21M)
Approx. gross sale proceeds $3.21M
Approx. exercise cost $859K
Type Security Shares Price Value
Exercise Options to purchase common stock F4 62,369 $0.00 $0.00
Exercise Options to purchase common stock F4 4,620 $0.00 $0.00
Exercise Options to purchase common stock F4 9,030 $0.00 $0.00
Exercise Options to purchase common stock F4 7,981 $0.00 $0.00
Exercise Common Stock 62,369 $10.23 $638K
Sale Common Stock F1, F2, F3 41,022 $72.86 $2.99M
Exercise Common Stock 4,620 $10.23 $47K
Sale Common Stock F1 651 $72.41 $47K
Exercise Common Stock 9,030 $10.23 $92K
Sale Common Stock F1 1,271 $72.41 $92K
Exercise Common Stock 7,981 $10.23 $82K
Sale Common Stock F1 1,123 $72.41 $81K
Holdings After Transaction: Options to purchase common stock — 243,548 shares (Direct); Options to purchase common stock — 18,040 shares (Indirect, By Spouse); Options to purchase common stock — 35,260 shares (Indirect, By Irrevocable Spousal Trust for Linda W. Cyr); Options to purchase common stock — 31,152 shares (Indirect, By Linda W. Cyr 2020 Irrevocable Trust for Descendants); Common Stock — 267,152 shares (Direct); Common Stock — 33,503 shares (Indirect, By Spouse); Common Stock — 76,150 shares (Indirect, By Irrevocable Spousal Trust for Linda W. Cyr); Common Stock — 69,836 shares (Indirect, By Linda W. Cyr 2020 Irrevocable Trust for Descendants)
Footnotes (4)
  1. F1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025.
  2. F2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.755 to $72.870.
  3. F3. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4.
  4. F4. The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020.
Options Exercised 84,000 shares Total underlying common shares from option exercises on August 17, 2026
Option Exercise Price $10.23 per share Exercise price for all reported stock options converted into common stock
Shares Sold Total 44,067 shares Aggregate common shares sold by Cyr and related entities on August 17, 2026
Direct Sale Price $72.86 per share Weighted average price for 41,022 directly held common shares sold
Indirect Sale Price $72.41 per share Price for indirect common share sales by spouse and related trusts
Remaining Direct Options 243,548 options Options to purchase common stock held directly by Cyr after transactions
Remaining Indirect Options (Spouse) 18,040 options Options held indirectly through spouse after transactions
Remaining Indirect Options (Trusts) 35,260 and 31,152 options Options held indirectly via two Linda W. Cyr-related irrevocable trusts
Rule 10b5-1 trading plan financial
"The sales reported ... were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average price financial
"The price reported is a weighted average price. These shares were sold"
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
Omnibus Incentive Plan financial
"The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan"
An omnibus incentive plan is a single, flexible program a company uses to give employees and executives different types of pay tied to performance — for example stock options, restricted shares, cash bonuses and other awards — all governed by one set of rules. It matters to investors because it determines how many new shares may be created, how leaders are motivated and how much the company will spend on compensation over time; think of it as a master toolbox that affects both costs and the total share supply.
Irrevocable Spousal Trust financial
"By Irrevocable Spousal Trust for Linda W. Cyr"
Irrevocable Trust for Descendants financial
"By Linda W. Cyr 2020 Irrevocable Trust for Descendants"

FAQ

What did Freshpet (FRPT) CEO William B. Cyr do in this Form 4 filing?

William B. Cyr exercised 84,000 stock options at $10.23 per share and related entities sold 44,067 common shares on August 17, 2026, with sales executed under a Rule 10b5-1 trading plan.

How many Freshpet (FRPT) shares did the CEO exercise and at what price?

Cyr exercised options covering 84,000 shares of Freshpet common stock at an exercise price of $10.23 per share. These options were granted under the company’s 2014 Omnibus Incentive Plan and were fully vested as of December 31, 2020.

How many Freshpet (FRPT) shares were sold in this Form 4 and at what prices?

Entities associated with Cyr sold a total of 44,067 common shares. Directly, 41,022 shares were sold at a weighted average price of $72.86; indirect sales by spouse and trusts totaled 3,045 shares at $72.41 per share.

Were the Freshpet (FRPT) insider sales made under a Rule 10b5-1 plan?

Yes. The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by Cyr on November 5, 2025. This indicates the transactions followed a pre-arranged trading schedule rather than discretionary same-day decisions.

What option holdings remain for the Freshpet (FRPT) CEO after these transactions?

After the August 17, 2026 exercises, Cyr held 243,548 options directly, while related entities held 18,040, 35,260, and 31,152 options, respectively. All these options were issued under Freshpet’s 2014 Omnibus Incentive Plan and are fully vested.

Through which entities are some Freshpet (FRPT) holdings reported for the CEO?

Some holdings are reported indirectly, including shares and options held by his spouse, an Irrevocable Spousal Trust for Linda W. Cyr, and the Linda W. Cyr 2020 Irrevocable Trust for Descendants, reflecting family-related ownership structures.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Cyr William B.

(Last)(First)(Middle)
C/O FRESHPET, INC.
1450 US-206

(Street)
BEDMINSTER NEW JERSEY 07921

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Freshpet, Inc. [ FRPT ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
Chief Executive Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/17/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/17/2026M62,369A$10.23308,174D
Common Stock08/17/2026S(1)41,022D$72.86(2)(3)267,152D
Common Stock08/17/2026M4,620A$10.2334,154IBy Spouse
Common Stock08/17/2026S(1)651D$72.4133,503IBy Spouse
Common Stock08/17/2026M9,030A$10.2377,421IBy Irrevocable Spousal Trust for Linda W. Cyr
Common Stock08/17/2026S(1)1,271D$72.4176,150IBy Irrevocable Spousal Trust for Linda W. Cyr
Common Stock08/17/2026M7,981A$10.2370,959IBy Linda W. Cyr 2020 Irrevocable Trust for Descendants
Common Stock08/17/2026S(1)1,123D$72.4169,836IBy Linda W. Cyr 2020 Irrevocable Trust for Descendants
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Options to purchase common stock$10.2308/17/2026M62,369 (4)09/06/2026Common Stock62,369$0243,548D
Options to purchase common stock$10.2308/17/2026M4,620 (4)09/06/2026Common Stock4,620$018,040IBy Spouse
Options to purchase common stock$10.2308/17/2026M9,030 (4)09/06/2026Common Stock9,030$035,260IBy Irrevocable Spousal Trust for Linda W. Cyr
Options to purchase common stock$10.2308/17/2026M7,981 (4)09/06/2026Common Stock7,981$031,152IBy Linda W. Cyr 2020 Irrevocable Trust for Descendants
Explanation of Responses:
1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2025.
2. The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $72.755 to $72.870.
3. The reporting person undertakes to provide to Freshpet, Inc., any security holders of Freshpet, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set in this Form 4.
4. The options were issued pursuant to the Issuer's 2014 Omnibus Incentive Plan. These options are fully vested as of December 31, 2020.
/s/ Andrew Lampert, as attorney-in-fact for the Reporting Person08/19/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)